Crocodile Capital Partners GmbH
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 21, 2025), Crocodile Capital Partners GmbH reported 10 stock positions worth $35.9 million. Its top holding was Barrick Gold (B) at 63.0% of the portfolio, followed by Newmont (NEM, 10.6%) and Biontech SE-ADR (BNTX, 9.4%). Compared with Q3 2024, it opened 5 new positions, sold out of 2, added to 1 and reduced 1. The biggest buy was Barrick Gold (B, shares +97%) and the biggest sale Alpha Metallurgical Resource (AMR, shares −98%).
- Most Recent 13F
- Q2 2026
- Location
- URSENSOLLEN, 2M
- CIK
- 0001956498
- Portfolio Value
- $35.9M (Q4 2024)
- SEC Filing
- 0001085146-25-000359 ↗ filed Jan 21, 2025
Holdings Value
Holdings 10 stocks · $35.9M
| B Barrick Gold Corp. | 63.03% | 1,460,000 | $22.6M | Add +97.3% |
| NEM Newmont Corp. | 10.58% | 102,055 | $3.8M | No change |
| BNTX Biontech SE-ADR | 9.39% | 29,586 | $3.4M | No change |
| SHEL Shell PLC-ADR | 5.68% | 32,546 | $2.0M | No change |
| CRESY Cresud S.A.-Spons ADR | 2.81% | 80,000 | $1.0M | New |
| BBAR Bbva Argentina SA-ADR filed as BANCO BBVA ARGENTINA S A | 2.12% | 40,000 | $762K | New |
| BMA Banco Macro SA-ADR | 2.02% | 7,500 | $726K | New |
| GGAL Grupo Financiero Galicia-ADR | 1.74% | 10,000 | $623K | New |
| IRS Irsa -SP ADR filed as IRSA INVERSIONES Y REP S A | 1.51% | 36,217 | $541K | New |
| AMR Alpha Metallurgical Resource | 1.11% | 2,000 | $400K | Reduce -98.0% |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $147.0M | UBS, AMR, IBKR, CRESY, AMZN |
| Q1 2026 | 12 | $139.8M | UBS, AMR, IBKR, AMZN, CRESY |
| Q4 2025 | 15 | $167.3M | UBS, AMR, GDX, IBKR, AMZN |
| Q3 2025 | 12 | $122.9M | B, UBS, GDX, NEM, BNTX |
| Q2 2025 | 11 | $59.5M | UBS, GDX, NEM, BNTX, YPF |
| Q1 2025 | 12 | $70.7M | B, UBS, NEM, GDX, BNTX |
| Q4 2024 | 10 | $35.9M | B, NEM, BNTX, SHEL, CRESY |
| Q3 2024 | 7 | $70.9M | AMR, B, MSFT, TMUS, NEM |
| Q2 2024 | 7 | $62.8M | AMR, MSFT, TMUS, NEM, SHEL |
| Q1 2024 | 7 | $72.5M | AMR, MSFT, SHEL, TMUS, NEM |